Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001903360-24-000002
Filing Date
2024-09-20
Accepted
2024-09-20 10:13:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 SEC SCHEDULE 13G SEC13G_Filing.htm SC 13G 17222
  Complete submission text file 0001903360-24-000002.txt   18734
Mailing Address 12406 HORESHAM STREET CARMEL IN 46032
Business Address 12406 HORESHAM STREET CARMEL IN 46032 3179893100
MBX Biosciences, Inc. (Subject) CIK: 0001776111 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94623 | Film No.: 241312024
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 280 CONGRESS STREET BOSTON MA 02210
Business Address 280 CONGRESS STREET BOSTON MA 02210 617-951-5000
Wellington Biomedical Innovation Master Investors (Cayman) II L.P. (Filed by) CIK: 0001903360 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9
Type: SC 13G